ISSN 1016-5169 | E-ISSN 1308-4488
Neurofibromatosis type 1 and cardiac manifestations [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2015; 43(8): 714-716 | DOI: 10.5543/tkda.2015.27557

Neurofibromatosis type 1 and cardiac manifestations

Faruk İncecik1, Özlem M Hergüner1, Sevcan Alınç-erdem2, Şakir Altunbaşak1
1Department of Pediatric Neurology, Çukurova University Faculty of Medicine, Balcali Hospital, Adana
2Department of Pediatric Cardiology, Çukurova University Faculty of Medicine, Balcali Hospital, Adana

Objective: Cardiac manifestations of neurofibromatosis type 1 (NF1) may include hypertension, congenital heart disease, and hypertrophic cardiomyopathy. The aim of this study was to evaluate cardiac abnormalities in patients with NF1.
Methods: Sixty-five NF1 patients (mean age: 9±4.48 years) were retrospectively studied. Standard electrocardiography and echocardiography were performed in all patients.
Results: Cardiac abnormalities were found in 11 of the 65 patients (15.3%). Five patients had mitral valve regurgitation, 2 patients had secundum atrial septal defect, 1 patient had pulmonary valvular stenosis, 1 patient had ventricular septal defect, 1 patient had tricuspid valve regurgitation, and 1 patient had aortic valve regurgitation.
Conclusion: Cardiac abnormalities have potential long-term hemodynamic consequences that justify an early diagnosis. Thus, for any patient with NF1, a cardiologic assessment is mandatory at the time of diagnosis and with regular follow-up intervals.

Keywords: Cardiac abnormalities, children, neurofibromatosis type 1


Corresponding Author: Faruk İncecik, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2025 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.